EU enlargement commissioner says launching clusters with Ukraine and Moldova is "absolutely necessary"
Source: Marta Kos, European Commissioner for Enlargement, at a meeting of the European Parliament's Foreign Affairs Committee on 3 June, as reported by European Pravda
Details: Kos stressed that Ukraine and Moldova are ready to open the first cluster, and the EU Council must find ways to do so.
"We absolutely need to take the next step with Ukraine and Moldova. Now, both countries have done their homework. Everything is ready and in the hands of the Council to open the first cluster," she noted.
Kos reiterated that "EU accession for Ukraine is a key security guarantee. We need to make it a reality".
"We need to process the move forward, to keep up momentum for reform in Ukraine, to help our member states tackle their concerns and ultimately to respond to our biggest security challenges since the end of the Second World War," she said.
Marta Kos also mentioned the progress in reforms that Ukraine was demonstrating.
"Thirty-six reform indicators have been met with continued efforts in traditional reform, anti-corruption, energy market liberalisation, corporate governance and the business climate. These reforms achieved under the most difficult conditions are not abstract. They directly support Ukraine's EU accession and bring it closer to the Union in every sense, politically, legally and economically," Kos stated.
Background:
Brussels is developing a scenario for parallel negotiations on Ukraine's accession to the EU bypassing Hungary – the first steps in its implementation have already been taken, although they prefer not to announce this officially.
On 27 May, János Bóka, Hungarian Minister for EU Affairs, stated that Hungary would continue to block Ukraine's accession to the EU due to espionage scandals.
Read more: "Plan B" for Ukraine's EU accession: how Brussels is preparing to overcome Hungary's veto
Support Ukrainska Pravda on Patreon!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment
New TBS Osteo Advanced next-generation software enhances fracture risk detection beyond standard of care in osteoporosis, a silent disease affecting over 32 million Europeans1 TBS Osteo Advanced next-generation software to be rolled-out across Europe Broad clinical adoption reinforces TBS Osteo leadership in bone microarchitecture evaluation for fracture risk assessment Subscription-based model offers ongoing services and access to future clinical innovations GENEVA, July 03, 2025--(BUSINESS WIRE)--Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, announces the European launch of its MDR-cleared next-generation TBS Osteo Advanced software. Following the product launch in the United States last month, this next milestone reflects the company's commitment to advancing osteoporosis detection and bone health management worldwide. The TBS Osteo Advanced software delivers refined correction for soft tissue thickness anterior to the lumbar spine, ensuring inclusivity of TBS assessment across a wide range of body phenotypes. It also introduces new system management capabilities, allowing hospitals and healthcare networks to centrally manage the TBS software on their DXA systems fleet, and to standardize workflows across multiple locations. These improvements enhance operational efficiency, streamline clinical processes, and ensure consistent patient care. TBS Osteo is available through a convenient subscription model, a flexible option providing customers with eligibility for software updates, new features and support services. This approach ensures healthcare organizations stay up to date with the latest innovations in osteoporosis care. Current TBS Osteo users have the possibility to upgrade to the next generation version and to take advantage of the new capabilities. "The TBS Osteo next-generation software has been developed with busy radiology professionals in mind for a maximum of clinical output with a minimum of logistics. The software is seamlessly integrated into the clinical workflow and performed at time of DXA scan. This approach sets TBS Osteo apart from competition," said Univ. Prof. Dr. Didier Hans, CEO and Co-founder of Medimaps Group. "TBS Osteo delivers within seconds a comprehensive report combining BMD and clinical factors, providing results beyond the standard of care. Adopted by many top hospitals across the world, including in the U.S., DXA and TBS Osteo have become the gold standard to detect and monitor osteoporosis." Since its initial launch in 2012, TBS Osteo has been widely adopted across the world, to support the assessment and management of osteoporosis. The software is backed by over 1,400 peer-reviewed publications and endorsed by more than 30 national and international osteoporosis assessment and management guidelines. In Europe, the software has received clearance from the Medical Device Regulation (MDR) and remains the only approved medical software for bone microarchitecture evaluation in clinical practice. Osteoporosis is a condition that weakens bones and increases the risk of fractures. Fractures due to osteoporosis have a devastating impact on millions of people worldwide and result in enormous socio-economic costs to society and healthcare systems. According to the International Osteoporosis Foundation, approximately 32 million Europeans aged 50 or over have osteoporosis. The annual number of osteoporotic fractures across the European Union, Switzerland, and the United Kingdom is projected to rise from 4.33 million in 2019 to 5.34 million by 2034 - an increase of over 1 million fractures annually¹. Despite the availability of effective treatments to reduce fracture risk, only 1 in 5 patients who experience an osteoporotic fracture are diagnosed or receive appropriate therapy¹. References International Osteoporosis Foundation (IOF), Last accessed: June 24, 2025 About Medimaps Group Founded by medical practitioners and clinical researchers, Medimaps combines Swiss innovation with a global presence to lead in bone health management. We provide healthcare professionals worldwide with advanced AI-driven software that enables comprehensive bone microarchitecture assessment. Our passion for musculoskeletal health is underpinned by scientific knowledge, collaborations with world-class academics, clinicians, industry partners, and direct patient engagement. The science behind our cutting-edge imaging applications and clinical evidence forms the core of our company's DNA. Medimaps Group, headquartered in Geneva, Switzerland, has offices in the United States and France. Its U.S. affiliate, Medimaps Group USA LLC, markets the company products and services. Learn more at View source version on Contacts Saoyuth Nidh Global Corporate Communications ManagerMob: +41 79 969 77 57snidh@
Business Wire
27 minutes ago
- Business Wire
Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment
GENEVA--(BUSINESS WIRE)--Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, announces the European launch of its MDR-cleared next-generation TBS Osteo Advanced software. Following the product launch in the United States last month, this next milestone reflects the company's commitment to advancing osteoporosis detection and bone health management worldwide. TBS Osteo next-generation is available through a convenient subscription model, a flexible option providing customers with eligibility for software updates, new features and support services. Share The TBS Osteo Advanced software delivers refined correction for soft tissue thickness anterior to the lumbar spine, ensuring inclusivity of TBS assessment across a wide range of body phenotypes. It also introduces new system management capabilities, allowing hospitals and healthcare networks to centrally manage the TBS software on their DXA systems fleet, and to standardize workflows across multiple locations. These improvements enhance operational efficiency, streamline clinical processes, and ensure consistent patient care. TBS Osteo is available through a convenient subscription model, a flexible option providing customers with eligibility for software updates, new features and support services. This approach ensures healthcare organizations stay up to date with the latest innovations in osteoporosis care. Current TBS Osteo users have the possibility to upgrade to the next generation version and to take advantage of the new capabilities. 'The TBS Osteo next-generation software has been developed with busy radiology professionals in mind for a maximum of clinical output with a minimum of logistics. The software is seamlessly integrated into the clinical workflow and performed at time of DXA scan. This approach sets TBS Osteo apart from competition,' said Univ. Prof. Dr. Didier Hans, CEO and Co-founder of Medimaps Group. 'TBS Osteo delivers within seconds a comprehensive report combining BMD and clinical factors, providing results beyond the standard of care. Adopted by many top hospitals across the world, including in the U.S., DXA and TBS Osteo have become the gold standard to detect and monitor osteoporosis.' Since its initial launch in 2012, TBS Osteo has been widely adopted across the world, to support the assessment and management of osteoporosis. The software is backed by over 1,400 peer-reviewed publications and endorsed by more than 30 national and international osteoporosis assessment and management guidelines. In Europe, the software has received clearance from the Medical Device Regulation (MDR) and remains the only approved medical software for bone microarchitecture evaluation in clinical practice. Osteoporosis is a condition that weakens bones and increases the risk of fractures. Fractures due to osteoporosis have a devastating impact on millions of people worldwide and result in enormous socio-economic costs to society and healthcare systems. According to the International Osteoporosis Foundation, approximately 32 million Europeans aged 50 or over have osteoporosis. The annual number of osteoporotic fractures across the European Union, Switzerland, and the United Kingdom is projected to rise from 4.33 million in 2019 to 5.34 million by 2034 - an increase of over 1 million fractures annually¹. Despite the availability of effective treatments to reduce fracture risk, only 1 in 5 patients who experience an osteoporotic fracture are diagnosed or receive appropriate therapy¹. References International Osteoporosis Foundation (IOF), Last accessed: June 24, 2025 About Medimaps Group Founded by medical practitioners and clinical researchers, Medimaps combines Swiss innovation with a global presence to lead in bone health management. We provide healthcare professionals worldwide with advanced AI-driven software that enables comprehensive bone microarchitecture assessment. Our passion for musculoskeletal health is underpinned by scientific knowledge, collaborations with world-class academics, clinicians, industry partners, and direct patient engagement. The science behind our cutting-edge imaging applications and clinical evidence forms the core of our company's DNA. Medimaps Group, headquartered in Geneva, Switzerland, has offices in the United States and France. Its U.S. affiliate, Medimaps Group USA LLC, markets the company products and services. Learn more at
Business Wire
28 minutes ago
- Business Wire
Verdane Invests in Guardsquare to Scale Mobile Security Solutions for All Businesses
LEUVEN, Belgium & BOSTON--(BUSINESS WIRE)-- Verdane, the European specialist growth investment firm, is entering a partnership with Guardsquare, a leader in mobile application security. The partnership follows previous investment from Battery Ventures and addresses the growing mobile app security threats by expanding access to GuardSquare's critical mobile application security for global businesses of all sizes. It also combines Guardsquare's deep technical expertise with Verdane's growth strategy through M&A and continued organic growth. Guardsquare's industry-leading mobile application protection is a critical cybersecurity service, and we're excited to partner with Roel and the entire Guardsquare team to make this available for even more businesses globally. Mobile applications are increasingly becoming the primary way users interact with businesses. Yet, mobile app security needs have historically remained underserved, especially as threat actors target mobile apps at an accelerated pace. Verdane's investment enables Guardsquare to expand its reach in providing the most comprehensive approach to mobile application security on the market, delivering the highest level of protection with ease. Earlier this year, Cyber Defense Magazine recognized Guardsquare as the market leader in Mobile App Security and honored the company with its prestigious Mobile App Security Award. 'I'm excited to embark on this new partnership with Verdane. It marks an inspiring and well-aligned progression toward our long-term vision. We will benefit from their expertise as, together, we take Guardsquare to the next level, significantly expand our market share, and increase our global reach through organic growth, ongoing product enhancements, and M&A,' said Roel Caers, CEO at Guardsquare. 'We're grateful for the support provided by Battery Ventures over the past several years as we became the market leader in mobile application protection. Their guidance enabled us to scale our business globally and attract top talent, particularly in the U.S.' 'Guardsquare's industry-leading mobile application protection is a critical cybersecurity service, and we're excited to partner with Roel and the entire Guardsquare team to make this available for even more businesses globally. The company's growth from a European to a global leader has been very impressive to behold, and we're looking forward to supporting the company in its future journey,' said Morten Weicher, Partner at Verdane. 'It has been a privilege to partner with the Guardsquare team and support the company's growth journey. As it scaled its business, Guardsquare has consistently demonstrated its commitment to innovation and leadership in mobile application security,' said Dharmesh Thakker, Partner at Battery Ventures. 'We are confident that this new partnership with Verdane will open up many new growth opportunities and allow Guardsquare to continue to help set the standard for mobile application security worldwide.' Completion of the transaction is subject to customary regulatory approvals. About Verdane Verdane is an independent specialist growth investment firm that partners with tech-enabled and sustainable European businesses. Verdane can invest as a minority or majority investor, either in single companies or through portfolios of companies, and looks to invest inside two core growth themes; digitalisation and decarbonisation. Verdane has more than €8 billion in assets under management and its funds have made over 200 investments in fast-growing businesses since 2003. Verdane's team of over 150 investment professionals and operating experts, based out of Berlin, Munich, Copenhagen, Helsinki, London, Oslo and Stockholm, is dedicated to being the preferred growth partner to tech-enabled and sustainable businesses in Europe. Verdane is a UN PRI signatory and also a certified B Corporation, the most ambitious sustainability accreditation globally. The firm only backs businesses that pass its 2040 test, which indicates whether the company can thrive in a more sustainable future economy. Additionally, the Verdane Foundation, which is managed by the group, focuses on supporting sustainability globally and inclusion locally. About Guardsquare Guardsquare offers the most complete approach to mobile application security on the market, delivering the highest level of protection in the easiest possible way. Guardsquare's software integrates seamlessly across the development cycle, from app security testing to code hardening to real-time visibility into the threat landscape. Guardsquare products provide enhanced mobile application security from early in the development process through publication. More than 900 organizations worldwide across all major industries rely on Guardsquare to help them identify security risks and protect their mobile applications and SDKs against reverse engineering and tampering in the ever-evolving threat landscape. Learn more at and on LinkedIn. All trademarks recognized.
